Northern Trust’s Coherus Oncology CHRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.54M Buy
913,800
+120,487
+15% +$214K ﹤0.01% 3108
2025
Q4
$1.13M Sell
793,313
-57,105
-7% -$83.2K ﹤0.01% 3312
2025
Q3
$1.39M Sell
850,418
-45,290
-5% -$50.4K ﹤0.01% 3224
2025
Q2
$655K Sell
895,708
-51,416
-5% -$44.4K ﹤0.01% 3564
2025
Q1
$764K Sell
947,124
-59,381
-6% -$68.3K ﹤0.01% 3393
2024
Q4
$1.39M Buy
1,006,505
+109,770
+12% +$123K ﹤0.01% 3225
2024
Q3
$933K Sell
896,735
-17,011
-2% -$23.3K ﹤0.01% 3388
2024
Q2
$1.58M Sell
913,746
-7,895
-0.9% -$15.9K ﹤0.01% 3033
2024
Q1
$2.2M Sell
921,641
-44,377
-5% -$109K ﹤0.01% 2912
2023
Q4
$3.22M Buy
966,018
+3,673
+0.4% +$9.84K ﹤0.01% 2732
2023
Q3
$3.6M Buy
962,345
+166,108
+21% +$767K ﹤0.01% 2629
2023
Q2
$3.4M Buy
796,237
+32,569
+4% +$192K ﹤0.01% 2712
2023
Q1
$5.22M Buy
763,668
+12,648
+2% +$98.2K ﹤0.01% 2446
2022
Q4
$5.95M Sell
751,020
-6,104
-0.8% -$47K ﹤0.01% 2377
2022
Q3
$7.28M Buy
757,124
+10,280
+1% +$104K ﹤0.01% 2213
2022
Q2
$5.41M Buy
746,844
+41,644
+6% +$362K ﹤0.01% 2460
2022
Q1
$9.1M Sell
705,200
-25,902
-4% -$329K ﹤0.01% 2203
2021
Q4
$11.7M Sell
731,102
-10,132
-1% -$177K ﹤0.01% 2126
2021
Q3
$11.9M Sell
741,234
-19,175
-3% -$281K ﹤0.01% 2155
2021
Q2
$10.5M Buy
760,409
+39,634
+5% +$561K ﹤0.01% 2328
2021
Q1
$10.5M Sell
720,775
-35,048
-5% -$595K ﹤0.01% 2253
2020
Q4
$13.1M Sell
755,823
-17,923
-2% -$319K ﹤0.01% 2075
2020
Q3
$14.2M Sell
773,746
-35,559
-4% -$662K ﹤0.01% 1878
2020
Q2
$14.5M Buy
809,305
+28,711
+4% +$486K ﹤0.01% 1857
2020
Q1
$12.7M Buy
780,594
+1,963
+0.3% +$36.3K ﹤0.01% 1726
2019
Q4
$14M Sell
778,631
-12,595
-2% -$232K ﹤0.01% 1961
2019
Q3
$16M Buy
791,226
+94,773
+14% +$1.89M ﹤0.01% 1842
2019
Q2
$15.4M Buy
696,453
+31,834
+5% +$553K ﹤0.01% 1867
2019
Q1
$9.06M Buy
664,619
+14,075
+2% +$188K ﹤0.01% 2212
2018
Q4
$5.89M Sell
650,544
-10,624
-2% -$123K ﹤0.01% 2403
2018
Q3
$10.9M Buy
661,168
+94,468
+17% +$1.67M ﹤0.01% 2209
2018
Q2
$7.93M Buy
566,700
+89,400
+19% +$1.28M ﹤0.01% 2410
2018
Q1
$5.27M Buy
477,300
+8,760
+2% +$95.8K ﹤0.01% 2548
2017
Q4
$4.12M Sell
468,540
-128
-0% -$1.37K ﹤0.01% 2723
2017
Q3
$6.26M Buy
468,668
+4,612
+1% +$61K ﹤0.01% 2484
2017
Q2
$6.66M Buy
464,056
+56,122
+14% +$1.08M ﹤0.01% 2438
2017
Q1
$8.63M Buy
407,934
+50,743
+14% +$1.25M ﹤0.01% 2212
2016
Q4
$10.1M Sell
357,191
-20,826
-6% -$583K ﹤0.01% 2112
2016
Q3
$10.1M Buy
378,017
+16,922
+5% +$462K ﹤0.01% 2066
2016
Q2
$6.1M Buy
361,095
+91,915
+34% +$1.73M ﹤0.01% 2332
2016
Q1
$5.7M Buy
269,180
+2,448
+0.9% +$40.1K ﹤0.01% 2330
2015
Q4
$6.12M Buy
266,732
+7,336
+3% +$189K ﹤0.01% 2340
2015
Q3
$5.2M Buy
259,396
+130,920
+102% +$3.98M ﹤0.01% 2415
2015
Q2
$3.71M Buy
128,476
+38,378
+43% +$970K ﹤0.01% 2701
2015
Q1
$2.75M Buy
90,098
+20,109
+29% +$520K ﹤0.01% 2913
2014
Q4
$1.14M Buy
+69,989
New +$987K ﹤0.01% 3348

Other funds holding CHRS